Human keratin diseases: The increasing spectrum of disease and subtlety of the phenotype-genotype correlation

British Journal of Dermatology

Volumn 140, Issue 5, 1999, Pages 815-828

  Irvine, A D ^a   McLean, W H I ^b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Genetics; Genodermatosis; Intermediate filaments; Keratin; Mutation

Indexed keywords

KERATIN;

CONGENITAL CORNEA DYSTROPHY; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; EPIDERMOLYSIS BULLOSA SIMPLEX; GENE MUTATION; GENODERMATOSIS; GENOTYPE; HUMAN; INTERMEDIATE FILAMENT; KERATOSIS PALMOPLANTARIS; LIVER CIRRHOSIS; MONILETHRIX; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ANIMALS; HAIR DISEASES; HUMANS; INTERMEDIATE FILAMENTS; KERATINS; KERATOSIS; MULTIGENE FAMILY; MUTATION; NAIL DISEASES; NEVUS; PSEUDOGENES; SKIN ABNORMALITIES;

EID: 0032965997     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02810.x     Document Type: Review

References (113)

1. Quinlan RA, Hutchison CJ, Lane EB. Intermediate filaments. In: Protein Profiles (Sheterline P, ed.). London: Academic Press Ltd, 1994.
2. Parry DAD, Crewther WG, Fraser RDB et al. Structure of a-keratin: structural implication of the amino acid sequences of the type I and type II chain segments. J Mol Biol 1977; 113: 449-54.
3. Lane EB. Keratins. In: Connective Tissue and its Heritable Disorders Molecular, Genetic and Medical Aspects (Royce PM, Steinmann B, eds). New York: Wiley-Liss Inc., 1993: 237-47.
4. Steinert PM, Parry DAD. Intermediate filaments: conformity and diversity of expression and structure. Annu Rev Cell Biol 1985; 1: 41-65.
5. Hatzfeld M, Weber K. The coiled coil of in vitro assembled keratin filaments is a heterodimer of type I and II keratins: use of site-specific mutagenesis and recombinant protein expression. J Cell Biol 1990; 110: 1199-210.
6. Steinert PM. The two-chain coiled-coil molecule of native epidermal keratin intermediate filaments is a type I-type II heterodimer. J Biol Chem 1990; 265: 8766-74.
7. Conway JF, Parry DAD. Intermediate filament structure: 3. Analysis of sequence homologies. Int J Biol Macromol 1988; 10: 79-98.
8. Parry DAD. Primary and secondary structure of IF protein chains and mode of molecular organisation. In: Cellular and Molecular Biology of Intermediate Filaments (Goldman RD, Steinert PM, eds). New York: Plenum Press, 1990: 175-204.
9. Parry DAD, Steven AC, Steinert PM. The coiled-coil molecules of intermediate filaments consist of two parallel chains in exact axial register. Biochem Biophys Res Commun 1985; 127: 1012-18.
10. Quinlan RA, Cohlberg JA, Schiller DL et al. Heterotypic tetramer (A2D2) complexes of non-epidermal keratins isolated from cytoskeletons of rat hepatocytes and hepatoma cells. J Mol Biol 1984; 178: 365-88.
11. Geisler N, Kaufmann E, Weber K. Antiparallel orientation of the two double-stranded coiled coils in the tetrameric protofilament unit of intermediate filaments. J Mol Biol 1985; 182: 173-7
12. Potschka M. Structure of intermediate filaments. Biophys J 1986:49: 129-30.
13. Steinert PM. Structure, function and dynamics of keratin intermediate filaments. J Invest Dermatol 1993; 100: 729-34.
14. Steinert PM. Structural features of keratin intermediate filaments. J Invest Dermatol 1994; 103: S19-24.
15. Moll R, Franke WW, Schiller DL et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-24.
16. Fuchs E, Green H. Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 1980; 19:1033-42.
17. Sun T-T, Eichner R, Schermer A et al. Classification, expression and possible mechanisms of evolution of mammalian epithelial keratins: a unifying model. In: The Transformed Phenotype (Levine AJ, Vande Woude GF, Topp WC, Watson JD, eds), Vol. 1. New York: Cold Spring Harbor Laboratory Press, 1984.
18. Oshima RG, Howe WE, Klier G et al. Intermediate filament protein synthesis in preimplantation murine embryos. Dev Biol 1983; 99: 447-55.
19. Waseem A, Alexander CM, Steel JB et al. Embryonic simple epithelial keratins 8 and 18: chromosomal location emphasizes difference from other keratin pairs. New Biol 1990; 2: 464-78.
20. Roop DR, Huitfeldt H, Kilkenny A et al. Regulated expression of differentiation-associated keratins in cultured epidermal cells detected by monospecific antibodies to unique peptides of mouse epidermal keratins. Differentiation 1987; 35: 143-50.
21. Stasiak PC, Purkis PE, Leigh IM et al. Keratin 19: predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J Invest Dermatol 1989; 92: 707-16.
22. Cooper DN. Human gene mutation affecting RNA processing and translation. Ann Med 1993; 25: 11-17.
23. Takahashi K, Paladini RD, Coulombe PA. Cloning and characterisation of multiple human genes and cDNAs encoding highly related type II keratin 6 isoforms. J Biol Chem 1995; 270: 18581-92.
24. Savtchenko ES, Freedberg IM, Choi I-Y et al. Inactivation of human keratin genes: the spectrum of mutations in the sequence of an acidic keratin pseudogene. Mol Biol Evol 1988; 5: 97-108.
25. Jonkman MF, Heeres K, Pas HH et al. Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex. J Invest Dermatol 1996; 107: 764-9.
26. Lane EB, Rugg EL, Navsaria H et al. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 1992; 356: 244-6.
27. Bonifas JM, Rothman AL, Epstein EH. Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Sci 1991; 254: 1202-5.
28. Coulombe PA, Hutton ME, Letai A et al. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analysis. Cell 1991; 66: 1301-11.
29. Fine JD, Bauer EA, Briggaman RA et al. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa: a consensus report by the subcommittee on diagnosis and classification of the national epidermolysis bullosa registry. J Am Acad Dermatol 1991; 24: 119-35.
30. Lin AN, Carter DM. Epidermolysis Bullosa Basic and Clinical Aspects. New York: Springer-Verlag, 1992.
31. McLean WHI, Lane EB. Intermediate filaments in disease. Curr Opin Cell Biol 1995; 7: 118-25.
32. Horn HM, Priestley CC, Eady RAJ et al. The prevalence of epidermolysis bullosa in Scotland. Br J Dermatol 1997; 136: 560-4.
33. Hallopeau M. Nouvelle note sur la dermatose bulleuse héréditaire et traumatique. Ann Dermatol Syphilol 1898; 9: 721-8.
34. Gossage A. The inheritance of certain human abnormalities. Q J Med 1908; 1: 331-46.
35. Weber F. Recurrent bullous eruptions on the feet in a child. Proc R Soc Med 1926; 19: 72.
36. Cockayne E. Recurrent bullous eruption of the feet. Br J Dermatol 1938; 55: 358-62.
37. Köbner H. Hereditaere Anlage zur Blasenbildung (Epidermolysis bullosa hereditaria). Dtsch Med Wochenschr 1886; 12: 21-2.
38. Dowling GB, Meara RH. Epidermolysis bullosa resembling juvenile dermatitis herpetiformis. Br J Dermatol 1954; 66: 139-43.
39. Kero M. Epidermolysis bullosa in Finland: clinical features, morphology and relation to collagen metabolism. Acta Derm Venerol (Stockh) 1984; 110: 1-51.
40. Hachem-Zadeth S, Rappersberg K, Livishin R et al. Epidermolysis bullosa simplex Dowling-Meara in a large family. J Am Acad Dermatol 1988; 13: 702-6.
41. McGrath JA, Ishida-Yamamoto A, Tidman MJ et al. Epidermolysis bullosa simplex (Dowling-Meara): a clinicopathological review. Br J Dermatol 1992; 126: 421-30.
42. Anton-Lamprecht I, Schnyder UW. Epidermolysis bullosa herpetiformis Dowling-Meara: report of a case and pathomorphogenesis. Dermatology 1982; 164: 221-35.
43. Ishida-Yamamoto A, McGrath JA, Chapman SJ et al. Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin filament network involving keratins K5 and K14. J Invest Dermatol 1991; 97: 959-68.
44. Albers K, Fuchs E. Expression of mutant keratin cDNAs in epithelial cells reveals possible mechanisms for initiation and assembly of intermediate filaments. J Cell Biol 1989; 108: 1477-93.
45. Vassar R, Coulombe PA, Degenstein L et al. Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell 1991; 64: 365-80.
46. Humphries MM, Sheils DM, Farrar GJ et al. A mutation (Met-to-Arg) in the type I keratin (K14) gene responsible for autosomal dominant epidermolysis bullosa simplex. Hum Mutat 1993; 2: 37-42.
47. Rugg EL, Morley SM, Smith FJD et al. Missing links: keratin mutations in Weber-Cockayne EBS families implicate the central L12 linker domain in effective cytoskeleton function. Nature Genet 1993; 5: 294-300.
48. Chan Y-M, Yu Q-C, Fine J-D et al. The genetic basis of Weber-Cockayne epidermolysis bullosa simplex. Proc Natl Acad Sci USA 1993; 90: 7414-18.
49. Hovnanian A, Pollack E, Hilal L et al. A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex. Nat Genet 1993; 3: 327-32.
50. Rugg EL, McLean WHI, Lane EB et al. A functional 'knock-out' for human keratin 14. Genes Dev 1994; 8: 2563-73.
51. Chan Y, Anton-Lamprecht I, Yu QC et al. A human keratin 14 'knockout': the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein. Genes Dev 1994; 8: 2574-87.
52. Lloyd C, Yu QC, Cheng J et al. The basal keratin network of stratified squamous epithelia defining K15 function in the absence of K14. J Cell Biol 1995; 129: 1329-44.
53. Corden LD, Mellerio JE, Gratian MJ et al. Homozygous nonsense mutation in helix 2 of K14 causes severe recessive epidermolysis bullosa simplex. Hum Mutat 1998; 11: 279-85.
54. Fischer T, Gedde-Dahl TJ. Epidermolysis bullosa simplex and mottled pigmentation: a new dominant syndrome, 1: clinical and histological features. Clin Genet 1979; 15: 228-38.
55. Coleman R, Harper JI, Lake BD. Epidermolysis bullosa simplex with mottled pigmentation. Br J Dermatol 1993; 128: 679-85.
56. Uttam J, Hutton E, Coulombe PA et al. The genetic basis of epidermolysis bullosa simplex with mottled pigmentation. Proc Natl Acad Sci USA 1996; 93: 9079-84.
57. Irvine AD, McKenna KE, Jenkinson H, Hughes AE. A mutation in the V1 domain of keratin 5 causes epidermolysis bullosa simplex with mottled pigmentation. J Invest Dermatol 1997; 108: 809-10.
58. Anton-Lamprecht I. Genetically induced abnormalities of epidermal differentiation and infrastructure in ichthyosis and epidermolysis: pathogenesis, heterogeneity, fetal manifestations, and prenatal diagnosis. J Invest Dermatol 1983; 81 (Suppl ): 1495-565.
59. Ishida-Yamamoto A, McGrath JA, Judge MR et al. Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma). J Invest Dermatol 1992; 99: 19-26.
60. Fuchs E, Esteves RA, Coulombe PA. Transgenic mice expressing a mutant K10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis. Proc Natl Acad Sci USA 1992; 89: 6906-10.
61. Bonifas JM, Bare JW, Chen MA et al. Epidermolytic hyperkeratosis: linkage to keratin gene regions on chromosomes 12q and 17q in two families. J Invest Dermatol 1992; 98: 573 (Abstr).
62. Compton JG, DiGiovanna JJ, Santucci SK et al. Linkage of epidermolytic hyperkeratosis to the type II keratin gene cluster on chromosome 12q. Nat Genet 1992; 1: 301-5.
63. Rothnagel JA, Dominey AM, Dempsey LD et al. Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science 1992; 257: 1128-30.
64. Chipev CC, Korge BP, Markova N et al. A leucine-proline mutalion H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell 1992; 70: 621-8.
65. Cheng J, Syder AJ, Yu Q-C et al. The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell 1992; 70: 811-19.
66. Corden LD, McLean WHI. Human keratin diseases: hereditary fragility of specific epithelial tissues. Exp Dermatol 1996; 5: 297-307.
67. DiGiovanna JJ, Bale SJ. Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol 1994; 130: 1026-35.
68. Paller AS, Syder AJ, Chan YM et al. Genetic and clinical mosaicism in a type of epidermal nevus. N Engl J Med 1994; 331: 1408-15.
69. Moss C, Jones DO, Blight A et al. Birthmark due to cutaneous mosaicism for keratin 10 mutation. Lancet 1995; 345: 596.
70. Kimonis V, DiGiovanna JJ, Yang J-M et al. A mutation in the V1 end domain of keratin 1 in non-epidermolytic palmar-plantar keratoderma. J Invest Dermatol 1994; 103: 764-9.
71. Marekov LN, Steinert PM. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin and small proline rich protein-1 and protein-2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem 1995; 270: 17702-11.
72. Kouklis PD, Hutton E, Fuchs E. Making a connection: direct binding between keratin intermediate filaments and desmosomal proteins. J Cell Biol 1994; 127: 1049-60.
73. Siemens HW. Dichtung und Wahrheit über die 'Ichthyosis bullosa', mit Bemerkungen zur Systematik der Epidermolysen. Arch Dermatol Syph (Berl) 1937; 175: 590-608.
74. Murdoch ME, Leigh IM. Ichthyosis bullosa of Siemens and bullous ichthyosiform erythroderma - variants of the same disease? Clin Exp Dermatol 1990; 15: 53-6.
75. McLean WHI, Morley SM, Lane EB et al. Ichthyosis bullosa of Siemens - a disease involving keratin 2e. J Invest Dermatol 1994; 103: 277-81.
76. Collin C, Moll R, Kubicka S et al. Characterization of human cytokeratin 2, an epidermal cytoskeleton protein synthesized late during differentiation. Exp Cell Res 1992; 202: 132-41.
77. Steijlen P, Kremer H, Vakilzadeh F et al. Genetic linkage of the keratin type II gene cluster with ichthyosis bullosa of Siemens and with autosomal dominant ichthyosis exfoliativa. J Invest Dermatol 1994; 103: 282-5.
78. Rothnagel JA, Traupe H, Wojcik S et al. Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens. Nat Genet 1994; 7: 485-90.
79. Vörner H. Zur Kenntniss des Keratoma hereditarium palmare et plantare. Arch Dermatol Syphilol 1901; 56: 3-31.
80. Langbein L, Heid HW, Moll I et al. Molecular characterization of the body site-specific human epidermal cytokeratin 9: cDNA cloning, amino acid sequence, and tissue specificity of gene expression. Differentiation 1993; 55: 57-71.
81. Reis A, Kuster W, Eckardt R, Sperling K. Mapping of a gene for epidermolytic palmoplantar keratoderma to the region of acidic keratin gene cluster at 17q12-q21. Hum Genet 1992; 90: 113-16.
82. Reis A, Hennies H-C, Langbein L et al. Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK). Nat Genet 1994; 6: 174-9.
83. Jadassohn J, Lewandowsky F. Pachyonychia congenita. In: Jacobs Ikanographia Dermatologica, Vol. 1. Berlin: Urban and Schwarzenberg, 1906: 29.
84. Jackson ADM, Lawler SD. Pachyonychia congenita: a report of six cases in one family. Ann Eugen 1951; 16: 142-6.
85. Munro CS, Carter S, Bryce S et al. A gene for pachyonychia congenita is closely linked to the keratin gene cluster on 17q12-q21. J Med Genet 1994; 31: 675-8.
86. McLean WHI, Rugg EL, Lunny DP et al. Keratin-16 and keratin-17 mutations cause pachyonyehia-congenita. Nat Genet 1995; 9: 273-8.
87. Bowden PE, Haley JL, Kansky A et al. Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Nature Genet 1995; 10: 363-5.
88. Smith FJD, Corden LD, Rugg EL et al. Missense mutations in keratin 17 cause either pachyonychia congenita or a phenotype resembling steatocystoma multiplex. J Invest Dermatol 1997; 108: 220-3.
89. Smith FJD, Jonkman MF, van Goor H et al. A mutation in human keratin K6b produces a phenocopy or the K17 disorder pachyonychia congenita type 2. Hum Mol Genet 1998; 7: 1143-8.
90. Smith FJD, Steijlen PM, McKenna K et al. Cloning of multiple K16 genes and genotype-phenotype correlation in pachyonychia congenita type 1 and focal PPK. J Invest Dermatol 1998; 110: 502.
91. Shamsher MK, Navsaria HA, Stevens HP et al. Novel mutations in keratin 16 gene underlie focal non-epidermolytic palmoplantar keratoderma. Hum Mol Genet 1995; 4: 1875-81.
92. Covello SP, Smith FJD, Sillevis Smitt JH et al. Keratin 17 mutations cause either steatocystocytoma multiplex or pachyonychia congenita type 2. Br J Dermatol 1998; 139: 475-80.
93. Healy E, Holmes SC, Belgade C et al. A gene for monilethrix is closely linked to the keratin gene cluster on chromosome 12q. Hum Mol Genet 1995; 4: 2399-402.
94. Rogers M, Nischt R, Korge B et al. Human hair keratins: sequences, chromosomal localization and evidence for keratin isoforms. J Invest Dermatol 1995; 104: 576.
95. Winter H, Rogers MA, Langbein L et al. Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix. Nat Genet 1997; 16: 372-4.
96. Winter H, Rogers MA, Gebhardt M et al. A new mutation in the type II hair cortex keratin hHb1 involved in the inherited hair disorder monilethrix. Hum Genet 1997; 101: 165-9.
97. Jorgenson RJ, Levin S. While sponge nevus. Arch Dermatol 1981; 117: 73-6.
98. Rugg EL, McLean WHI, Allison WE et al. A mutation in the mucosal keratin K4 is associated with oral white sponge nevus. Nat Genet 1995; 11: 450-2.
99. Richard G. DeLaurenzi V, DiDona B et al. Keratin-13 point mutation underlies the hereditary mucosal epithelial disorder white sponge nevus. Nat Genet 1995; 11: 453-5.
100. Meesmann A, Wilke F. Klinische und anatomische Untersuchungen ueber eine bisher unbekannte, dominant vererbte Epitheldystrophie der Hornhaut. Klin Mbl Augenheilk 1939; 103: 361-91.
101. Fine BS, Yanoff M, Pitts E et al. Meesmann's epithelial dystrophy of the cornea. Am J Ophthalmol 1977; 83: 633-42.
102. Tremblay M, Dube I. Meesmann's corneal dystrophy: ultrastructural features. Can J Ophthalmol 1982; 17: 24-8.
103. Irvine AD, Corden LD, Swensson O et al. Mutations in cornea-specific keratins K3 or K12 cause Meesmann's corneal dystophy. Nature Genet 1997; 16: 184-7.
104. Nishida K, Honma Y, Dota A et al. Isolation and chromosomal localization of a cornea-specific human keratin 12 gene and detection of four mutations in Meesmann corneal epithelial dystrophy. Am J Hum Genet 1997; 61: 1268-75.
105. Ku NO, Wright TL, Terrault NA et al. Mutation of human keratin 18 in association with cryptogenic cirrhosis. J Clin Invest 1997; 99: 19-23.
106. Baribault H, Penner J, Iozzo RB et al. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev 1994; 8: 2964-73.
107. Green KJ, Jones JCR. Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB J 1996; 10: 871-81.
108. Christiano A. Frontiers in keratodermas: pushing the envelope. Trends Genet 1997; 13: 227-33.
109. McLean WHI, Pulkkinen L, Smith FJD et al. Loss of plectin causes epidermolysis-bullosa with muscular-dystrophy - cDNA cloning and genomic organization. Genes Dev 1996; 10: 1724-35.
110. Smith FJD, Eady RAJ, Leigh IM et al. Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nature Genet 1996; 13: 450-7.
111. Uitto J, Pulkkinen L, Smith FJD et al. Plectin and human genetic disorders of skin and muscle. The paradigm of epidermolysis bullosa with muscular dystrophy. Exp Dermatol 1996; 5: 237-46.
112. McGrath JA, McMillan JR, Shemanko CS et al. Mutations in the plakophilin 1 gene can result in ectodermal dysplasia/skin fragility syndrome. Nature Genet 1997; 17: 240-4.
113. Ku N, Lio J, Omary M. Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. EMBO J 1998; 17: 1892-906.